Drug intelligence / Profile preview

OVO Joint

Development stage
Unknown
Lead developer
MEDcell
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral
01

Overview

OVO Joint is a multi-ingredient nutraceutical supplement developed by Medcell Pharma for the comprehensive management of joint health, specifically targeting osteoarthritis and osteopenia. The formulation is a synergistic combination of four patented or standardized ingredients: Ovomet (eggshell membrane-derived collagen hydrolysate), Myrliq (Commiphora myrrha extract), ch-OSA (choline-stabilized orthosilicic acid), and sodium hyaluronate. These components are designed to reduce joint pain and inflammation while supporting the structural integrity of cartilage and bone density. Marketed as a specialty nutritional product rather than a pharmaceutical drug, OVO Joint represents a collaboration between Medcell Pharma and international partners Eggnovo (Spain), Biosfered (Italy), and BioMinerals (Belgium).

Brand names
OVO Joint
Other names
OVO-JOINTOVO Joint-MEDcell

Beyond the preview

Go deeper on OVO Joint.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OVO Joint.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call